Now in its twelfth year, the forum fosters open discussion of timely topics of mutual theoretical and practical interest to statisticians and clinical trialists who develop new drugs, biologics, and combination products. This unique forum advances the dialogue between industry, regulatory agencies, and academia.

Highlights

• Co-Sponsored with the FDA
• In-depth discussions on new and revised guidances
• Town Hall: An open discussion lead by an expert panel of leaders from industry and regulatory agencies
• Each session is co-chaired by an Industry-FDA team
• Two interactive half day Short Courses for even more in-depth knowledge-sharing
• Poster Presentations from researchers across the statistics field
• Luncheon Round Table Discussions on cutting-edge topics with key thought leaders
• DIA Statistics Open Community Meeting

Preconference Short Courses

• Artificial Intelligence, Machine Learning, and Precision Medicine
  This short course will provide an overview of statistical machine learning and artificial intelligence techniques with applications to precision medicine, in particular to deriving optimal individualized treatment strategies for precision medicine.
• Causal Inference: Weighting Methods and Case Studies
  This course will start with a general overview on causal inference methods using weighting and a case-study using IPW method, then we will introduce recently developed methodology of overlap weights, which places emphasis on clinical equipoise and has statistical advantages over IPW.

On-Demand Complimentary Webinar

Structured Exploration of Clinical Trial Data
Gain an overview of a structured approach for safely applying these more advanced methods, discuss their application in practice, and explore how they can be used to guide scientific research.